Status:
UNKNOWN
SSPC Evaluation on Carotid Artery Stenosis After Endarterectomy
Lead Sponsor:
Shanghai Pudong Hospital
Conditions:
Carotid Stenosis
Carotid Artery Diseases
Eligibility:
All Genders
50-90 years
Brief Summary
SSPC includes degree of Stenosis, Symptoms, Plaque stability and Compensation of the cerebral blood flow. SSPC, a comprehensive evaluation system on carotid artery stenosis, is established and advocat...
Detailed Description
Although, cerebral perfusion and collaterals recruitment are crucial and integral to current treatment and stroke prevention paradigms, most consensus recommendations do not include assessments of cer...
Eligibility Criteria
Inclusion
- Patient or patient's legal representative have been informed of the nature of the study, agrees to participate and has signed an Ethical Committee approved consent form
- Unilateral or bilateral carotid artery stenosis diagnosed by ultrasound or CT angiography.
- Complete revascularization followed by carotid endarterectomy or carotid artery stenting.
Exclusion
- Patients with carotid stenosis received best medicine therapy.
- Patients for whom antiplatelet therapy, anticoagulants, medium contrast, or thrombolytic drugs are contraindicated.
- Patient has bleeding diathesis, coagulopathy, known hypercoagulable condition or refuses blood transfusion
- female patient with childbearing potential not taking adequate contraceptives or currently breastfeeding.
- Life expectancy of less than twelve months.
- Patient is currently participating in another investigational drug or device study that has not completed the entire follow up period.
- Patient presenting one of the following comorbid conditions: hemodialysis, elevated creatine levels (\> 2.5mg/dl), recent MI or ischemic stroke occurrence (both within 30 days).
- Patient unwilling or unlikely to comply with Follow-Up schedule
Key Trial Info
Start Date :
April 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 30 2023
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05296876
Start Date
April 1 2022
End Date
November 30 2023
Last Update
May 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Pudong Hospital
Shanghai, Shanghai Municipality, China, 201200